Clinical Trial Update: Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating photobiomodulation therapy for safety and to reduce the incidence of oral mucositis in adults with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Photobiomodulation Therapy

Snippet

Sponsor: MuReva Phototherapy Inc. | Conditions: Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation | NA | Status: COMPLETED